Two-Dose Heartworm Treatment Shows 95 Percent Efficacy

A new clinical trial suggests that a two-dose melarsomine protocol could help animal shelters treat more dogs effectively.

Updated on Oct. 28, 2026 in Veterinary Medicine

Flat gouache-painted illustration of two medical syringes resting on a sterile surface near a folded blanket, representing canine veterinary care.
A two-dose heartworm treatment protocol achieved 95.3 percent efficacy in a recent clinical trial, potentially lowering treatment costs for animal shelters. AI Illustration. Upload story photo >

Live Poll

Do you believe new medical protocols are effectively reducing costs for local animal shelters?

A clinical trial concluded in December 2025 shows a two-dose heartworm treatment protocol achieves 95.3 percent efficacy in dogs. This research helps animal shelters assess alternative treatment plans for dogs with Class 1 or 2 heartworm disease.

Why it matters

Reducing heartworm treatment to two doses instead of three can significantly lower costs and resource requirements for animal shelters. This approach allows shelters to treat more heartworm-positive animals using existing budgets.

The study tracked 168 dogs with Class 1 or 2 heartworm disease, with 7 dogs requiring thoracic radiographs following treatment. All dogs in the study survived the treatment protocol.

The players

Lucky Dog Animal Rescue

An organization focused on rescuing and rehabilitating dogs for adoption.

University of Florida Shelter Medicine Program

An academic initiative dedicated to improving the health and welfare of animals in shelters.

Toronto Humane Society

A Canadian animal welfare organization providing care and medical treatment to homeless animals.

PetSmart Charities

A grant-making nonprofit organization that funds animal welfare programs and research.

The details

The two-dose protocol involves administering melarsomine injections on consecutive days 14 and 15, while the standard three-dose protocol spans days 14, 44, and 45. Researchers compared these methods to determine if the shortened, two-injection timeline could provide a viable alternative for managing heartworm cases in resource-constrained shelter environments.

Timeline

  1. The clinical trial took place from April 2024 to December 2025.

The Home Front

This study reflects a growing trend in veterinary medicine to optimize treatment protocols specifically for high-volume shelter environments. By balancing efficacy with resource efficiency, the research aims to address systemic challenges in managing common canine diseases.

If you are fostering or adopting a dog recently treated for heartworm in a shelter, consult your veterinarian about the specific protocol used and any necessary follow-up care. Keep all documentation of your pet's medical treatment history to ensure your local vet has a complete record for future wellness exams.

The takeaway

While the two-dose protocol shows high efficacy, the standard three-dose treatment remains the baseline for comparison in veterinary practice. Always consult your own licensed veterinarian regarding the most effective heartworm prevention and treatment plan for your specific dog.

Further reading

For more information on managing your pet's health, visit our Veterinary Medicine section.

Source note: This article includes information reported by Veterinary Practice News.

Live Poll

Do you believe new medical protocols are effectively reducing costs for local animal shelters?